Rapid Detection of Antibiotic Resistance in Group B Streptococcus
Author Information
Author(s): Wilfred P. Dela Cruz, Joann Y. Richardson, Judith M. Broestler, Jennifer A. Thornton, Patrick J. Danaher
Primary Institution: David Grant USAF Medical Center
Hypothesis
Can real-time PCR effectively predict in vitro resistance in Group B Streptococcus isolates?
Conclusion
The study found that a rapid PCR assay can predict clindamycin susceptibility in GBS isolates much faster than traditional methods.
Supporting Evidence
- The presence of erm genes predicted resistance to clindamycin with high sensitivity and specificity.
- Rapid PCR testing can reduce the time to determine antibiotic susceptibility from 18-24 hours to 1-2 hours.
- 31% of isolates contained at least one resistance gene, indicating a significant prevalence of resistance.
Takeaway
Scientists created a quick test to see if a type of bacteria called Group B Streptococcus can resist certain medicines, which helps doctors treat infections faster.
Methodology
Real-time PCR assays were developed and tested on 340 clinical GBS isolates, comparing results with conventional disk diffusion methods.
Limitations
The study did not test the PCR method directly on clinical specimens, which may limit its practical application.
Participant Demographics
Unique patient GBS isolates collected from vaginal-rectal swabs.
Statistical Information
Confidence Interval
95% CI 86%–97%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website